Dapagliflozin add-on to metformin in type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled 102-week trial

被引：0
|
作者：
Clifford J Bailey
Jorge L Gross
Delphine Hennicken
Nayyar Iqbal
Traci A Mansfield
James F List
机构：
[1] Aston University,Life and Health Sciences
[2] Universidade Federal do Rio Grande do Sul,Endocrine Division
[3] Bristol-Myers Squibb,Global Biometric Services
[4] Parc de l'Alliance,Global Clinical Research
[5] Bristol-Myers Squibb,undefined
来源：
BMC Medicine | / 11卷
关键词：
Dapagliflozin; metformin; SGLT2; sodium-glucose cotransporter 2; glycemic control; type 2 diabetes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Dapagliflozin Is Effective as Add-on Therapy to Sitagliptin With or Without Metformin: A 24-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study
    Jabbour, Serge A.
    Hardy, Elise
    Sugg, Jennifer
    Parikh, Shamik
    DIABETES CARE, 2014, 37 (03) : 740 - 750
  • [22] Efficacy and Safety of Dapagliflozin Add-on Therapy to Evogliptin plus Metformin Combinations in Inadequately Controlled Patients with Type 2 Diabetes-A 24-Week, Randomized, Double-blind, Placebo-Controlled, Parallel-Design, Phase 3 Trial
    Jeong, In-Kyung
    Choi, Kyung Mook
    Han, Kyung Ah
    Kim, Kyoung-Ah
    Kim, In Joo
    Han, Seung Jin
    Lee, Won-Young
    Yoo, Soon Jib
    DIABETES, 2023, 72
  • [23] Safety and efficacy of linagliptin as add-on therapy to metformin in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled study
    Taskinen, M. -R.
    Rosenstock, J.
    Tamminen, I.
    Kubiak, R.
    Patel, S.
    Dugi, K. A.
    Woerle, H. -J.
    DIABETES OBESITY & METABOLISM, 2011, 13 (01): : 65 - 74
  • [24] Metformin in gestational diabetes mellitus: A double-blind placebo-controlled randomized trial
    Tew, Min P.
    Tan, Peng C.
    Saaid, Rahmah
    Hong, Jesrine G. S.
    Omar, Siti Z.
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2022, 156 (03) : 508 - 515
  • [25] Combination of retagliptin and henagliflozin as add-on therapy to metformin in patients with type 2 diabetes inadequately controlled with metformin: A multicentre, randomized, double-blind, active-controlled, phase 3 trial
    Wang, Yao
    Jiang, Chengxia
    Dong, Xiaolin
    Chen, Mingwei
    Gu, Qin
    Zhang, Lihui
    Fu, Yanqin
    Pan, Tianrong
    Bi, Yan
    Song, Weihong
    Xu, Jing
    Lu, Weiping
    Sun, Xiaodong
    Ye, Zi
    Zhang, Danli
    Peng, Liang
    Lin, Xiang
    Dai, Wei
    Wang, Quanren
    Yang, Wenying
    DIABETES OBESITY & METABOLISM, 2024, 26 (07): : 2774 - 2786
  • [26] A Randomized, Double-Blind Trial of Saxagliptin Add-on to Dapagliflozin plus Metformin
    Matthaei, Stephan
    Catrinoiu, Doina
    Celinski, Aleksander
    Ekholm, Ella
    Cook, William
    Hirshberg, Boaz
    Iqbal, Nayyar
    Hansen, Lars
    DIABETES, 2015, 64 : A27 - A28
  • [27] Randomised, double-blind trial of dual add-on saxagliptin plus dapagliflozin vs saxagliptin or dapagliflozin add-on alone in poorly controlled type 2 diabetes on metformin
    Hansen, L.
    Zee, P.
    Li, Y.
    Cook, W.
    Hirshberg, B.
    Iqbal, N.
    Rosenstock, J.
    DIABETOLOGIA, 2014, 57 : S8 - S8
  • [28] A Randomized, Double-Blind, Phase 3 Trial of Dapagliflozin Add-on to Saxagliptin plus Metformin in Type 2 Diabetes
    Mathieu, Chantal
    Ranetti, Aurelian E.
    Li, Danshi
    Ekholm, Ella
    Cook, William
    Hirshberg, Boaz
    Hansen, Lars
    Iqbal, Nayyar
    DIABETES, 2015, 64 : A28 - A28
  • [29] Empagliflozin as Add-on Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Linagliptin and Metformin: A 24-Week Randomized, Double-Blind, Parallel-Group Trial
    Softeland, Eirik
    Meier, Juris J.
    Vangen, Bente
    Toorawa, Robert
    Maldonado-Lutomirsky, Mario
    Broedl, Uli C.
    DIABETES CARE, 2017, 40 (02) : 201 - 209
  • [30] Dapagliflozin versus saxagliptin as add-on therapy in patients with type 2 diabetes inadequately controlled with metformin
    Rosenstock, Julio
    Mathieu, Chantal
    Chen, Hungta
    Garcia-Sanchez, Ricardo
    Saraiva, Gabriela Luporini
    ARCHIVES OF ENDOCRINOLOGY METABOLISM, 2018, 62 (04): : 424 - 430
12345